Charles Jones v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2026)
Case summary [AI summaries can sometimes make mistakes]
On October 18, 2024, Charles Jones filed a petition alleging that an influenza vaccination administered on October 1, 2023 caused Guillain-Barre Syndrome, a Vaccine Injury Table injury. Respondent conceded entitlement in a Rule 4(c) report, and Chief Special Master Brian H.
Corcoran found Mr. Jones entitled to compensation on July 11, 2025.
The parties could not resolve damages and briefed pain and suffering. Mr.
Jones sought $185,000.00, describing a severe and debilitating GBS course. Respondent proposed $148,000.00, characterizing the illness as moderate while later acknowledging that Mr.
Jones had experienced upper and lower extremity weakness, deficits, and neurologic symptoms for at least two years. The Special Master compared the case to other GBS pain-and-suffering awards involving moderate symptoms, hospital and inpatient rehabilitation stays, and significant outpatient therapy.
On March 10, 2026, Chief Special Master Corcoran awarded $178,000.00 for past pain and suffering. No separate unreimbursed expenses, future expenses, or lost wages were awarded in the decision.
Theory of causation
Influenza vaccine on October 1, 2023, causing Table GBS; COMPENSATED. Respondent conceded entitlement. Damages contested: petitioner sought $185,000; respondent proposed $148,000; decision credited moderate but significant GBS with upper/lower extremity weakness and neurologic symptoms persisting at least two years. Award $178,000 past pain/suffering only. Chief SM Brian H. Corcoran; petition filed October 18, 2024; entitlement July 11, 2025; damages March 10, 2026.
Source PDFs
USCOURTS-cofc-1_24-vv-01697